Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steroid-Refractory Chronic GVHD”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Early research (Phase 1)Looking for participantsNCT06991361
What this trial is testing

Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD

Who this might be right for
Graft Versus Host Disease (cGvHD)
Leslie Kean 21
Testing effectiveness (Phase 2)Ended earlyNCT01475162
What this trial is testing

Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease

Who this might be right for
Acute Graft Versus Host Disease
Medical College of Wisconsin 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT01366092
What this trial is testing

Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease

Who this might be right for
Chronic Graft-versus-host Disease
Dana-Farber Cancer Institute 35
Testing effectiveness (Phase 2)Ended earlyNCT04232397
What this trial is testing

Anlotinib Treatment in Steroid Depenent/Refractory cGVHD

Who this might be right for
Chronic Graft-versus-host-disease
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 5
Post-approval studies (Phase 4)Not Yet RecruitingNCT06364319
What this trial is testing

Efficacy and Safety of Anti-CD25 rhMAb in the Treatment of Steroid-Refractory cGVHD

Who this might be right for
cGVHD
Peking University People's Hospital 30
Testing effectiveness (Phase 2)Study completedNCT03007238
What this trial is testing

Extracorporeal Photopheresis and Low Dose Aldesleukin in Treating Patients With Steroid Refractory Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft Versus Host Disease
City of Hope Medical Center 10
Early research (Phase 1)Study completedNCT03683498
What this trial is testing

Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-host-Disease

Who this might be right for
Chronic Graft vs Host Disease
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 16
Testing effectiveness (Phase 2)Study completedNCT00003894
What this trial is testing

Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant

Who this might be right for
Graft Versus Host DiseaseUnspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific
Roswell Park Cancer Institute 36
Early research (Phase 1)Active Not RecruitingNCT04212416
What this trial is testing

Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host Disease

Who this might be right for
Chronic Graft Versus Host DiseaseSteroid Refractory Graft Versus Host Disease
City of Hope Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT02340676
What this trial is testing

A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory cGVHD

Who this might be right for
Chronic Graft-versus-host-disease
Dana-Farber Cancer Institute 25
Early research (Phase 1)Study completedNCT00529035
What this trial is testing

Ultra-Low Dose Interleukin-2 for Refractory Chronic Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
Dana-Farber Cancer Institute 29
Early research (Phase 1)Study completedNCT01672229
What this trial is testing

Bortezomib in Patients With Chronic Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
Mehrdad Abedi, MD 16
Testing effectiveness (Phase 2)Study completedNCT02997280
What this trial is testing

Ruxolitinib for Steroid-refractory GVHD

Who this might be right for
Graft Vs Host Disease
St. Petersburg State Pavlov Medical University 75
Large-scale testing (Phase 3)Study completedNCT02959944
What this trial is testing

Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Chronic Graft Versus Host Disease
Pharmacyclics LLC. 193
Testing effectiveness (Phase 2)Ended earlyNCT01903473
What this trial is testing

Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Chronic Graft-Versus-Host DiseaseAcute Graft-Versus-Host DiseaseSteroid Refractory Graft-Versus-Host Disease
University of Liege 19
Testing effectiveness (Phase 2)Study completedNCT00136396
What this trial is testing

Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
Dana-Farber Cancer Institute 30
Testing effectiveness (Phase 2)UnknownNCT05095649
What this trial is testing

Donor Regulatory T-cells for cGVHD in Patients Who do Not Obtain Complete Remission With Ruxolitinib

Who this might be right for
Chronic Graft vs Host Disease
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 15
Not applicableStudy completedNCT05052385
What this trial is testing

ECP Combination Study

Who this might be right for
Steroid Refractory GVHD
European Society for Blood and Marrow Transplantation 319
Not applicableAvailableNCT04745637
What this trial is testing

Managed Access Programs for INC424, Ruxolitinib

Who this might be right for
Primary Myelofibrosis (PMF)Post Polycythemia Myelofibrosis (PPV MF)Thrombocythemia Myelofibrosis (PET-MF)+4 more
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02824653
What this trial is testing

Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD

Who this might be right for
Graft Versus Host Disease
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 10
Next Page